The question of strengthening the research capacities in drug innovation
DOI:
https://doi.org/10.21518/1561-5936-2018-3-6-15Keywords:
innovation, medicinal product, small innovative enterprise, intellectual deliverables, pharmaceutical science, the pharmaceutical industryAbstract
The article deals with the institutional mechanisms for strengthening the research capacities in the development of innovative drugs, involving the improvement of the following institutions: state procurement, marketing authorization of drugs, government support for small and medium-sized businesses, state scientific and technical policy, science and education, international relations.References
Морозов Д.: Потенциал рынка дженериков будет исчерпан в течение двух лет. Интерфакс. Режим доступа: http://www.interfax-russia.ru /NorthWest /exclusives.asp?id=869067 (дата обращения: 30.11.2017 г.).
Semin A.A. State support for research in pharmacology: an analysis of foreign and domestic experience. Research Result: Pharmacology and Clinical Pharmacology, 2017, 3 (3): 157-168.
Семин А.А. Факторы инновационного развития фармацевтической отрасли: информационно-аналитические материалы. М.: Московский Политех, 2017. 85 с.
Приказ Минпромторга России № 1605, Минздрава России № 308н «Об утверждении перечня биомишеней для разработки схожих по фармакотерапевтическому действию и улучшенных аналогов инновационных лекарственных препаратов» от 19.05.2016 г. (Зарегистрировано в Минюсте России 08.06.2016 г. № 42464).
Наркевич И.А., Трофимова Е.О., Дельвиг-Каменская Т.Ю. Проблема подготовки кадров для российской фармацевтической отрасли и пути ее преодоления. Инновации, 2013, 7 (177): 3-8.
Семин А.А., Шувалов С.С. Проблемы научного обеспечения проектов импортозамещения в фармацевтической промышленности. Ремедиум, 2017, 1-2: 46-50.
Трофимова Е.О., Дельвиг Т.Ю. Основы классификации инноваций в сфере создания лекарственных средств. Новая аптека, 2009, 1: 43-48.
Семин А.А. Оценка эффективности государственных расходов на НИОКТР в фармацевтике. Современная организация лекарственного обеспечения, 2017, 3-4: 36-45.
Наркевич И.А., Флисюк Е.В., Семин А.А. и др. Аддитивные технологии для фармацевтики. Химико-фармацевтический журнал, 2017, 51 (11): 40-44.
Фабричный С.Ю., Семин А.А., Наркевич И.А. Обоснование перспектив изучения природных соединений как источника создания лекарственных средств для коррекции жирового и углеводного обмена. Разработка и регистрация лекарственных средств, 2017, 4 (21): 126-131.
Downloads
Published
Issue
Section
License
Authors retain copyright and grant the journal right of the first publication. The article simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
By submitting the article and accompanying files (hereinafter – the “Work”) the author (all the authors of the work, if it is created in co-authorship) agrees that he provides OAO Izdatelstvo Meditsina exclusive and perpetual right to use the work free of charge (exclusive, perpetual and royalty-free license) on the territory of Russia and foreign countries in the following ranges and volume:
- the publication of works on paper and / or electronic format, producing reprints of works, placing it on the Internet, both in the open and paid access, sending works metadata or full text indexing to various databases and repositories;
- reproduction of the work, i.e. the production of one or more copies of a work or part thereof in any material form, including in the form of audio or video recording. Recording on electronic media, including recording in computer memory, is also considered as a reproduction;
- distribution of works through sale or other alienation of its original or copies;
- public display of the work, that is, any demonstration of the original or copy of a work, either directly or on the screen using film, slide, television pictures or other technical means, as well as a demonstration of individual frames of an audiovisual work without concern for their order, either directly or with the help of technical means in a place open for free visits, or in a place where a significant number of individuals do not belong to the normal family, regardless of the perceived in the place of its display or elsewhere at the same time demonstrating product;
- import-export of the work or its parts for any lawful purpose (paid and gratis);
- translation or other processing of the works;
- bringing the work to the public so that anyone can access the work from any place and at any time of their choice;
- accommodation of works or parts thereof in a variety of collections of similar works;
- granting of rights in full or in part to third (physical and legal) persons at both the paid and free of charge.
Author’s items are not provided. The title is available by subscription.
